<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-164055</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cerebral metastasis of ovarian epithelial cancer: case study</dc:title>
<dc:description xml:lang="en">Case: 50-year-old woman diagnosed and treated for primary ovarian cancer in 1996. She underwent optimal cytoreductive surgery and adjuvant chemotherapy. Nine years later, she developed brain metastatic lesion, and was treated with both surgery and whole-brain radiotherapy. She is currently 4 years post-treatment of her brain metastases without evidence of disease-free. Conclusion: These patients have a poor prognosis, with studies reporting a mean survival of 12 months. However, the patient in this report remains disease-free since her treatment for metastatic disease. Aggressive surgical and radiation treatment for patients with isolated central nervous system metastases can be a reasonable option in selected patients (AU)</dc:description>
<dc:creator>Xercavins, Jordi</dc:creator>
<dc:creator>Sánchez-Iglesias, José Luis</dc:creator>
<dc:creator>Gómez Cabeza, Juan José</dc:creator>
<dc:creator>Rabasa Antonijuan, Jordi</dc:creator>
<dc:creator>Gil-Moreno, Antonio</dc:creator>
<dc:creator>Pérez-Ceresuela, Francesc</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso: mujer de 50 años de edad, diagnosticada y tratada de un carcinoma epitelial de ovario en 1996. Se realizó cirugía citorreductora óptima y quimioterapia adyuvante. Nueve años más tarde, desarrolló una lesión metastásica cerebral tratada con cirugía y radioterapia holocraneal. Cuatro años después del tratamiento sigue sin evidencia de enfermedad. Conclusión: estas pacientes tienen un pronóstico pobre, con estudios que reportan una supervivencia media de 12 meses. Sin embargo, nuestra paciente se mantiene libre de la enfermedad, por lo que en pacientes con metástasis única, la cirugia y la radioterapia son la mejor opción de tratamiento (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);60(2): 140-142, mar.-abr. 2017.</dc:source>
<dc:identifier>ibc-164055</dc:identifier>
<dc:title xml:lang="es">Metástasis cerebral de cáncer epitelial de ovario: estudio de un caso</dc:title>
<dc:subject>^d29853^s22045</dc:subject>
<dc:subject>^d24373^s22002</dc:subject>
<dc:subject>^d54678^s22045</dc:subject>
<dc:subject>^d10229^s22009</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d10229^s22012</dc:subject>
<dc:subject>^d4371^s29166</dc:subject>
<dc:subject>^d9555^s22032</dc:subject>
<dc:subject>^d10229^s22059</dc:subject>
<dc:subject>^d4371^s22053</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201704</dc:date>
</metadata>
</record>
</ibecs-document>
